{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:08Z","timestamp":1794047468061,"version":"4.8.0"},"reference-count":10,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285213","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T03:22:41Z","timestamp":1713410561000},"page":"2775-2777","source":"Crossref","is-referenced-by-count":3,"title":["&lt;i&gt;TP53&lt;\/i&gt; binding domain mutations are bad news in Burkitt lymphoma"],"prefix":"10.3324","volume":"109","author":[{"given":"Mitchell S.","family":"Cairo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"65184","doi-asserted-by":"crossref","unstructured":"Martire G, Lovisa F, Carraro E. TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification. Haematologica. 2024; 109(9):3031-3036.","DOI":"10.3324\/haematol.2023.284868"},{"key":"65185","doi-asserted-by":"crossref","unstructured":"Goldman S, Barth M, Shiramizu B. A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma. Leukemia. 2021; 35(10):2994-2997.","DOI":"10.1038\/s41375-021-01256-8"},{"key":"65186","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Anderson JR. Rituximab and FAB\/ LMB 96 chemotherapy in children with Stage III\/IV B-cell non-Hodgkin lymphoma: a Children\u2019s Oncology Group report. Leukemia. 2013; 27(5):1174-1177.","DOI":"10.1038\/leu.2012.255"},{"key":"65187","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Galardy P. Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/ leukaemia: a Children\u2019s Oncology Group Report. Br J Haematol. 2014; 167(3):394-401.","DOI":"10.1111\/bjh.13040"},{"key":"65188","doi-asserted-by":"crossref","unstructured":"Minard-Colin V, Auperin A, Pillon M. Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N Engl J Med. 2020; 382(23):2207-2219.","DOI":"10.1056\/NEJMoa1915315"},{"key":"65189","doi-asserted-by":"crossref","unstructured":"Lee S, Luo W, Shah T. The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL. Oncotarget. 2017; 8(17):27839-27853.","DOI":"10.18632\/oncotarget.15711"},{"key":"65190","doi-asserted-by":"crossref","unstructured":"Poirel HA, Cairo MS, Heerema NA. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study. Leukemia. 2009; 23(2):323-331.","DOI":"10.1038\/leu.2008.312"},{"key":"65191","doi-asserted-by":"crossref","unstructured":"Wong D, Luo P, Oldfield LE. Early cancer detection in Li-Fraumeni syndrome with cell-free DNA. Cancer Discov. 2024; 14(1):104-119.","DOI":"10.1158\/2159-8290.CD-23-0456"},{"key":"65192","doi-asserted-by":"crossref","unstructured":"Leroy B, Anderson M, Soussi T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Hum Mutat. 2014; 35(6):672-688.","DOI":"10.1002\/humu.22552"},{"key":"65193","doi-asserted-by":"crossref","unstructured":"Cairo MS. A new Burkitt \u201clook-alike\u201d lymphoma. Blood. 2019; 133(9):889-891.","DOI":"10.1182\/blood-2019-01-894329"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285213\/76867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285213\/77417","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11557\/76867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:15Z","timestamp":1794045975000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285213","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,18]]}}}